Prevalencia de obesidad presarcopénica en personas mayores chilenasResultados de la Encuesta Nacional de Salud 2016-2017

  1. Yeny Concha-Cisternas 1
  2. Felipe Díaz 2
  3. José Castro-Piñero 3
  4. Fabian Lanuza 4
  5. Nicole Laserre 5
  6. Ana María Leiva-Ordoñez 6
  7. Igor Cigarroa 7
  8. Gabriela Nazar 8
  9. Solange Parra-Soto 9
  10. Carlos Celis-Morales 10
  11. Fanny Petermann-Rocha 11
  1. 1 Universidad Santo Tomás, Talca, Chile; Universidad Autónoma de Chile, Talca, Chile
  2. 2 Universidad Andrés Bello Santiago, Chile
  3. 3 University of Cadiz, Puerto Real, Cádiz, Spain; Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA), Cádiz, Spain
  4. 4 Universidad de La Frontera, Temuco, Chile
  5. 5 Universidad Santo Tomás, Los Ángeles, Chile
  6. 6 Universidad Austral de Chile, Valdivia, Chile
  7. 7 Universidad Santo Tomás, Los Ángeles, Chile; Universidad Santo Tomás, Chile
  8. 8 Universidad de Concepción, Chile
  9. 9 University of Glasgow, Glasgow, United Kingdom; Universidad del Bío-Bío, Chillan, Chile
  10. 10 University of Glasgow, Glasgow, United Kingdom; University Católica del Maule, Talca, Chile
  11. 11 University of Glasgow, Glasgow, United Kingdom; Universidad Diego Portales, Santiago, Chile
Revista:
Revista española de nutrición humana y dietética

ISSN: 2173-1292

Ano de publicación: 2023

Volume: 27

Número: 2

Páxinas: 153-162

Tipo: Artigo

DOI: 10.14306/RENHYD.27.2.1875 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

Outras publicacións en: Revista española de nutrición humana y dietética

Resumo

Introduction: There are no studies in Chile that quantify the prevalence of pre-sarcopenic obesity. Therefore, this study aimed to determine the prevalence of pre-sarcopenic obesity in Chilean older adults. Methodology: 240 people ≥60 years from the Chilean National Health Survey 2016-2017 were included. Pre-sarcopenia was estimated with the handgrip test and obesity was defined using waist circumference. As a sensitivity analysis, obesity was classified in a subsample of 129 people using body mass index (BMI). Based on the obesity and muscle strength criteria, the participants were categorized as: normal; obesity/ normal; normal/pre-sarcopenia and obesity/pre-sarcopenia. Results: 22.6% of the population presented obesity/pre-sarcopenia using waist circumference as a diagnostic parameter. The prevalence of pre-sarcopenic obesity was higher in women (22.9%), in older people (33.0%), with urban residence (22.8%), and lower educational levels (37.3%). By incorporating the BMI as an obesity criterion, a decrease in the prevalence of pre-sarcopenic obesity (12.2%) and a higher percentage of women with this phenotype were identified. Conclusions: The prevalence of pre-sarcopenic obesity was identified in 22.6% of the older Chilean population included. Considering the role of obesity and sarcopenia in the development of non-communicable diseases, its identification and early detection could allow the creation of interventions that favours the survival and health of the elderly

Referencias bibliográficas

  • Conde-Ruiz JI, González CI. El proceso de envejecimiento en España. Estudios sobre la economía española-2021/07. 2021. Citado 5 de enero de 2022]. Disponible en: https://documentos.fedea.net/pubs/eee/eee2021-07.pdf
  • Jentoft AJC, Baeyens JP, Bauer JM, Boirie Y, CederholmT, Landi F, et al. Sarcopenia: consenso europeo sobre su definición y diagnóstico. Informe del Grupo europeo de trabajo sobre la sarcopenia en personas de edad avanzada Oxfford University: Age and Ageing. 2010;39(4):412-23. doi: 10.1093/ageing/afq034
  • Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and ageing. 2019;48(1):16-31. doi.org/10.1093/ageing/afy169
  • Kao T-W, Peng T-C, Chen W-L, Han D-S, Chen C-L, Yang W-S. Impact of adiposity on muscle function and clinical events among elders with dynapenia, presarcopenia and sarcopenia: a community-based cross-sectional study. Aging (Albany NY). 2021;13(5):7247. doi: 10.18632/aging.202581
  • Gonzalez A, Simon F, Achiardi O, Vilos C, Cabrera D, Cabello-Verrugio C. The Critical Role of Oxidative Stress in Sarcopenic Obesity. Oxidative Medicine and Cellular Longevity. 2021;2021. doi.org/10.1155/2021/4493817
  • Purcell SA, Mackenzie M, Barbosa-Silva TG, Dionne IJ, Ghosh S, Siervo M, et al. Prevalence of sarcopenic obesity using different definitions and the relationship with strength and physical performance in the Canadian longitudinal study of aging. Frontiers in physiology. 2021;11:583825. doi.org/10.3389/fphys.2020.583825
  • Xie W-q, Xiao G-l, Fan Y-b, He M, Lv S, Li Y-s. Sarcopenic obesity: research advances in pathogenesis and diagnostic criteria. Aging clinical and experimental research. 2021; 33:247-52
  • Polyzos SA, Margioris AN. Sarcopenic obesity. Hormones. 2018; 17:321-31.
  • Murawiak M, Kuzminskas-Siemaszko R, Kaluźniak-Szymanowska A, Lewandowicz M, Tobis S, Wieczorowska-Tobis K, et al. Sarcopenia, Obesity, Sarcopenic Obesity and Risk of Poor Nutritional Status in Polish Community-Dwelling Older People Aged 60 Years and Over. Nutrients. 2022;14(14):2889. doi.org/10.3390/nu14142889
  • Lera L, Angel B, Marquez C, Saguez R, Albala C. Besides Sarcopenia, pre-sarcopenia also predicts all-cause mortality in older chileans. Clinical Interventions in Aging. 2021;16:611. doi: 10.2147/CIA.S289769
  • Ministerio, de Salud M. Encuesta Naciona de Salud 2016-2017: primeros resultados. 2017. [citado 5 de enero de 2022]. Disponible en:
  • Ministerio de Salud (MINSAL) Departamento de Epidemiología. Encuentra Nacional de Salud 2016-2017. citado 5 de enero de 2022]. Disponible en:
  • http://epi.minsal.cl/wpcontent/uploads/2021/06/Informe_estado_nutricional_ENS2016_2017.pdf
  • Romero-Dapueto C, Mahn J, Cavada G, Daza R, Ulloa V, Antúnez M. Estandarización de la fuerza de prensión manual en adultos chilenos sanos mayores de 20 años. Revista médica de Chile. 2019;147(6):741-50. doi: 10.2147/CIA.S289769
  • Michael Marfell-Jones TO, Arthur Stewart and Lindsay Carter. Estándares Internacionales para mediciones antropométricas- ISAK. 2006. [citado 5 de
  • enero de 2022]. Disponible en: https://www.uninut.org/images/material_ponentes/37/2/Estandares_Internacionales_para_la_medicion_antropometrica.pdf
  • Petermann-Rocha F, Martínez-Sanguinetti MA, Ho FK, Celis-Morales C, Pizarro A. Optimal cut-off points for waist circumference in the definition of metabolic syndrome in Chile. Public Health Nutrition. 2020;23(16):2898-903.
  • Organización Panamericana de la Salud (OPS). Parte 1: Módulos de Valoración clínica. Módulo 5: Valoración Nutricional del Adulto Mayor, 2003. [citado 5 de
  • enero de 2022]. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENT/valoracion-nutricional-persona-adulta-mayor.pdf
  • Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obesity facts. 2022;15(3):321-35.
  • Word Health Organization (WHO). Global Physical Activity Questionnaire: GPAQ version 2.0. 2009. [citado 5 de enero de 2022]. Disponible en: https://www.who.int/publications/m/item/global-physical-activity-questionnaire
  • De Oliveira TM, Roriz AKC, Medeiros JMB, Ferreira AJF, Ramos LB. Sarcopenic obesity in community-dwelling older women, determined by different diagnostic methods. Nutrición hospitalaria: Organo oficial de la Sociedad española de nutrición parenteral y enteral. 2019;36(6):1267-72. DOI: 10.20960/nh.02593
  • Chung J-Y, Kang H-T, Lee D-C, Lee H-R, Lee Y-J. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Archives of gerontology and geriatrics. 2013;56(1):270-8. doi.org/10.1016/j.archger.2012.09.007
  • Santana NdM, Mendes RML, Silva NFd, Pinho CPS. Sarcopenia and sarcopenic obesity as prognostic predictors in hospitalized elderly patients with acute myocardial infarction. Einstein (Sao Paulo). 2019;17(4):1-9. doi.org/10.31744/einstein_journal/2019AO4632
  • Yakout SM, Alkahtani SA, Al-Disi D, Aljaloud KS, Khattak MNK, Alokail MS, et al. Coexistence of pre-sarcopenia and metabolic syndrome in Arab men. Calcified Tissue International. 2019;104(2):130-6. doi: 10.1007/s00223-018-0477-2
  • Wang T, Feng X, Zhou J, Gong H, Xia S, Wei Q, et al. Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly. Scientific reports. 2016;6(1):1-7. DOI: 10.1038/srep38937
  • Kobayashi K, Ando K, Tsushima M, Machino M, Ota K, Morozumi M, et al. Predictors of presarcopenia in community-dwelling older adults: A 5-year longitudinal study. Modern rheumatology. 2019;29(6):1053-8. doi.org/10.1080/14397595.2018.1551171
  • Pereira FB, Leite AF, Paula APd. Relationship between pre-sarcopenia, sarcopenia and bone mineral density in elderly men. Archives of endocrinology and metabolism. 2015;59:59-65. doi.org/10.1590/2359-3997000000011
  • Organización para la Cooperación y el Desarrollo Económicos (OCDE). Obesity Update 2017. 2017. [citado 5 de enero de 2022]. Disponible en: https://www.oecd.org/els/health-systems/Obesity-Update-2017.pdf
  • Zhang X, Xie X, Dou Q, Liu C, Zhang W, Yang Y, et al. Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings: a updated meta-analysis. BMC geriatrics. 2019;19(1):1-14. doi.org/10.1111/ggi.12579
  • Prado C, Wells J, Smith S, Stephan B, Siervo M. Sarcopenic obesity: a critical appraisal of the current evidence. Clinical nutrition. 2012;31(5):583-601. https://doi.org/10.1159/000521241
  • Leiva AM, Troncoso-Pantoja C, Martínez-Sanguinetti MA, Nazar G, Concha-Cisternas Y, Martorell M, et al. Personas mayores en Chile: el nuevo desafío social, económico y sanitario del Siglo XXI. Revista médica de Chile. 2020;148(6):799-809. doi.org/10.4067/S0034-98872020000600799
  • Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nature Reviews Endocrinology. 2018;14(9):513-37. doi: 10.1038/s41574-018-0062-9.